Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	$ (743,420)	$ (655,736)
Net loss	(20,599)	(18,780)
Ending Balance	$ (764,019)	$ (674,516)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,899,575	1,899,575
Beginning Balance	$ 1,900	$ 1,900
Ending Balance (in shares)	1,899,575	1,899,575
Ending Balance	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	8,418,684	8,418,684
Ending Balance	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	(9,164,004)	(9,076,320)
Net loss	(20,599)	(18,780)
Ending Balance	$ (9,184,603)	$ (9,095,100)